SFX


Editorial image
(L-R) Jean-Daniel Carrard, syndic of Yverdon, Herve Hoppenot, CEO of the American pharmaceutical company Incyte, Philippe Leuba, state councillor of Vaud, Michael Morrissey, Corporate Senior Vice President of Incyte, and Juliana Pantet, director Y-Parc, during a press conference about a new branch of the Incyte on the site of the technology park Y-PARC in Yverdon, Switerland, 07 November 2017.
pharmaceutical company Incyte new branch, Yverdon-Les-Bains, Switzerland - 07 Nov 2017
pharmaceutical company Incyte new branch, Yverdon-Les-Bains, Switzerland - 07 Nov 2017
pharmaceutical company Incyte new branch, Yverdon-Les-Bains, Switzerland - 07 Nov 2017
pharmaceutical company Incyte new branch, Yverdon-Les-Bains, Switzerland - 07 Nov 2017
pharmaceutical company Incyte new branch, Yverdon-Les-Bains, Switzerland - 07 Nov 2017
9210248f

Stock Image ID: 9210248f

pharmaceutical company Incyte new branch, Yverdon-Les-Bains, Switzerland - 07 Nov 2017

(L-R) Jean-Daniel Carrard, syndic of Yverdon, Herve Hoppenot, CEO of the American pharmaceutical company Incyte, Philippe Leuba, state councillor of Vaud, Michael Morrissey, Corporate Senior Vice President of Incyte, and Juliana Pantet, director Y-Parc, during a press conference about a new branch of the Incyte on the site of the technology park Y-PARC in Yverdon, Switerland, 07 November 2017.

Important information

Image Formats

  • 5003 × 2916 pixels • JPG

Image Contributor

Jean-Christophe Bott/EPA-EFE/Shutterstock